Pacliaqualip 100mg Injection is a vital medication used in the treatment of various types of cancer. Its active ingredient, Paclitaxel, is a potent chemotherapy agent that works by interfering with the growth of cancer cells, ultimately leading to their death. Paclitaxel belongs to a class of drugs known as taxanes. It functions by stabilizing microtubules, which are essential components of the cell structure and are critical for cell division. By preventing the breakdown of microtubules, Pacliaqualip halts cell division and proliferation, particularly in rapidly dividing cancer cells.
Pacliaqualip 100mg Injection is indicated for the treatment of advanced ovarian cancer, breast cancer, and non-small cell lung cancer. It may also be used in combination with other chemotherapy drugs for certain types of cancer. The dosage and duration of treatment are determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health and response to therapy. It is administered intravenously.
Common side effects may include hair loss, nausea, vomiting, diarrhea, bone marrow suppression (leading to low blood cell counts), and peripheral neuropathy (numbness or tingling in the hands and feet). Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Pacliaqualip 100mg Injection should be stored at room temperature, protected from light, and should not be refrigerated.
